Business Development Spotlight with Christopher Bjerkan Wade
Discover more about our team. In this Spotlight, meet our Senior Business Development Director, Christopher Bjerkan Wade.
December 11, 2025
With you from pre-clinical to market.
Discover a science-led approach with unparalleled project delivery.
About Us
Your integrated CDMO partner of choice for oral, nasal and pulmonary dosage forms.
As a leading Contract, Development and Manufacturing Organisation (CDMO) our defining traits lie in our adaptability and nimbleness.
Through our science-led approach we align to your drug development needs from pre-clinical to late phase manufacture, across oral solid dosage forms, liquids, semi-solids, nasal and inhaled products.
Our CDMO Services
Science-led expertise providing
unparalleled project delivery.
Our team support you at each stage of your drug program lifecycle from pre-clinical to market.
Our CDMO services include formulation development, phase 1, phase 2 and phase 3 clinical supply, process scale-up and optimisation, quality control, analytical development and validation, and registration activities.
Our Project Delivery
The right conversations with
experts across our business.
Our project teams are made up of subject experts from across our business. With oversight from an Executive Leadership Team member on every project, our approach ensures you can have open and transparent conversations, enabling quick decision-making and collaboration across our business to ensure your project’s success.
Our Development and GMP Manufacturing Facility
An award-winning facility
built to meet your patient targets.
Our award-winning 50,000 sqft development and manufacturing facility, Trent Gateway, enables our teams to be flexible and nimble so that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.
Our Mission.
Passionate about science, we strive to build strong customer relationships and exceed their expectations.
We develop and manufacture high-quality drug products and share in our customers’ dedication to change the lives of patients.
Sign up to our insights
Fill in your details to be added to our newsletter list and receive our latest news and insights.
Upperton Wins at European Celebration of CDMO Excellence: Winner of Small Molecule Dosage Form Category
Upperton announces its recognition as winner of the Small Molecule Dosage Form category at the inaugural European CDMO Leadership Awards.
October 20, 2025